Incidence and Survival Outcomes of Colorectal Cancer in Long-Term Metformin Users with Diabetes: A Population-Based Cohort Study Using a Common Data Model
Seung In Seo et al, 2022, Journal of Personalized Medicine CrossRef
Emerging Roles of Wnt Ligands in Human Colorectal Cancer
Xiaobo Nie et al, 2020, Frontiers in Oncology CrossRef
Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes
Qi-You Huang et al, 2020, World Journal of Clinical Cases CrossRef
Metformin and colorectal cancer
GAST覰 AMABLE et al, 2022, BIOCELL CrossRef
Canonical WNT/β-catenin signaling upregulates aerobic glycolysis in diverse cancer types
Meetu Rathee et al, 2024, Molecular Biology Reports CrossRef
Metformin-induced chemosensitization to cisplatin depends on P53 status and is inhibited by Jarid1b overexpression in non-small cell lung cancer cells
Tharcisio Citrangulo Tortelli et al, 2021, Aging CrossRef
Impact of diabetes and metformin use on recurrence and outcome in stage II–III colon cancer patients—A pooled analysis of three adjuvant trials
Niki Christou et al, 2022, European Journal of Cancer CrossRef
Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression
Cheng-Ann Winston Ng et al, 2020, International Journal of Colorectal Disease CrossRef
Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment
L. E. Anselmino et al, 2021, Scientific Reports CrossRef
Anti-ENO1 antibody combined with metformin against tumor resistance: a novel antibody-based platform
Xiong Shu et al, 2024, PeerJ CrossRef
Ferritinophagic Flux Activation in CT26 Cells Contributed to EMT Inhibition Induced by a Novel Iron Chelator, DpdtpA
Yanjie Sun et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
DpdtC-Induced EMT Inhibition in MGC-803 Cells Was Partly through Ferritinophagy-Mediated ROS/p53 Pathway
Jiankang Feng et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef